NEWS

Welcome to UBIFRANCE, the french Trade Commission Portal

News in your activities

Search

French Tech Ticket - Season 2: Submit Your Startup Project Today!

PRESS - 27-juil.-2016 16:07:28

  French Tech Ticket - season 2: Submit your startup project today! Apply to the global competition and get a chance to grow your startup in a booming ecosystem! 70 selected startups will be awarded a full package of benefits including a 45,000 Euros prize money, 1-year incubation, a dedicated masterclass programme… and much more! Your startup project is in BioTech, Mobile/Web, Big Data, FinTech, Social Innovation or any other industry? With over 40 partner incubators all over France to choose from, you’ll find the right one to lead you to success! The competition is open to entrepreneurs from all over the world and there’s only one month left to apply! Check out the French Tech Ticket website for more information and apply online before August 24 th ! www.frenchtechticket.com  

PRESS: Defymed Receives Support from JDRF to Fight Type 1 Diabetes

PRESS - 13-juil.-2016 00:41:48

Defymed Receives Support from JDRF to Fight Type 1 Diabetes JDRF will contribute up to $500,000 in funds to finance preclinical studies on the MAILPAN ® bioartificial pancreas NEW YORK, July XX 2016 – Defymed, a French biotechnology company specializing in the development of bioartificial organs today announced a partnership with JDRF, the leading global organization funding type 1diabetes (T1D) research. This new investment gives Defymed the opportunity to advance its pre-clinical studies in order to demonstrate the MAILPAN ® immunoprotection properties, safety and function. This is an essential step before beginning the clinical trials on humans. " JDRF is known as the number-one worldwide public foundation fighting type 1 diabetes. We are more than honored to be working with them for the necessary pre-clinical tests before starting the MAILPAN® clinical phase ," explains Dr. Séverine Sigrist, CEO of Defymed. " More than financial support, JRDF brings to us considerable visibility within the U.S. market and also provides strategic support in regards to finding a solution to encapsulating insulin-secreting cells to derive the benefits offered by this therapy to patients suffering from type 1 diabetes." With this support, Defymed will move significantly forward with clinical trials in humans. This new project, scheduled to take up to 24 months, will be conducted simultaneously as other research and development programs currently in progress at Defymed. It will allow Defymed to test the MAILPAN® bioartificial pancreas designed for type 1 diabetics through the preclinical phase in order to: - Strengthen the results on MAILPAN ® ’s immunoprotection properties in combination with insulin-secreting cells. - Confirm collected data on the MAILPAN ®’s functionality and safety , also in combination with insulin-secreting cells. MAILPAN® , a disruptive technology for a better life Almost 25 million people around the world suffer from type 1 diabetes. MAILPAN®, an implantable bioartificial pancreas, is a serious alternative to existing treatments. This medical device is designed to restore normal and continuous insulin production in diabetic patients. Implanted in the abdomen, it takes the shape of a pouch containing insulin-secreting cells. The potential of MAILPAN® will bring numerous advantages in comparison to current treatments (e.g., no anti-rejection drugs in case of pancreatic transplants, absence of multiple insulin injections per day). The bioartificial pancreas’ underlying principle’ is to encapsulate insulin-secreting cells between membranes impermeable to the immune system, but permeable enough for oxygen, nutrients, glucose and insulin. A bioartificial pancreas must fulfill three prerequisite functions: to protect transplanted cells from the patient immune system, to protect the patient from transplanted cells, and to maximize the function of the transplanted cells. The goal of the project is to ensure the function and safety of the medical device, utilizing Defymed’s expertise in the biomaterial and cell transplant , as well as preclinical validation and non-invasive imaging technologies. This strategic step for Defymed confirms the therapeutic interest of the MAILPAN® and will generate preclinical data that is absolutely necessary to build strong regulatory documentation for the MAILPAN® , associated with insulin-secreting cells, which will be necessary to bring it to clinical trials in humans. "JDRF is excited to announce its support of Defymed as it seeks preclinical validation of its MAILPAN® device, a project which is well aligned with JDRF’s Beta Cell Replacement strategy," said Derek Rapp, JDRF president and CEO. "By funding this type of research, we firmly believe we are moving one step closer to our goal of creating a world without type 1 diabetes. Major challenges for Alsatian biotech JRDF support appears as a testament of confidence and represents an important opportunity for Defymed to make significant strides in the biotech world. It will indeed bring more visibility and awareness to French biotech on an international platform. From a strategic standpoint, this financial support will also allow Defymed to pursue its development in Europe but also to prepare its entry in its new target market, the U.S. Defymed has also become a member of the encapsulation consortium, a key JDRF initiative. Its goal is to accelerate the development of a bioartificial pancreas for individuals living with type 1 diabetes. For the complete press release, click the link below    

FRENCH ART OF FURNISHING: 6 companies to keep an eye on at M&O Americas

Geoffroy THAUMIN - 20-avr.-2016 20:35:39

For the very first time, the GEM –the export department of the French furniture industry association– is bringing together six major French furniture players at Maison & Objet Americas. A first step in the US for the GEM, this rendez-vous with French furniture will be followed by many more! The FRENCH ART OF FURNISHING Pavilion will be located booths #1312-1417.  Among the exhibitors: Gautier and its extensive range of stylish and contemporary furniture, but also Maison Montaigne Paris, who represents more than 16 European brands in their Miami showroom. Visitors will also be introduced to Fermob, Sifas and Vlaemynck. Renowned internationally for their premium and luxury outdoors furniture, their designs are created with grace and manufactured to last. Last but not least, Objet de Curiosité will showcase their many wonders, from decorative shells to steampunk lights and from exotic butterflies to mysterious stones. Already successful in France, and for some of them in the US, where their craftsmanship is recognized in niche or mainstream markets, our exhibitors are excited to present their latest designs during the show. For more information about the Pavilion or our exhibitors, please read our online catalogue .

Strong U.S.-France Relationship Good for Global Economy

Muriel Pénicaud - 18-avr.-2016 20:44:10

As the world continues to recover from the Great Recession and further unites against global threats to our security and the safety of our citizens, the importance of growing and bolstering the global economy is an increasing priority for many nations. It is a logical conclusion for those who recognize that an invigorated economic foundation is vital and is in the best interest of the entire planet. In that light, France has made it a top priority to create an environment that is welcoming to business—whether startups or established, French created or multinational. To shine a spotlight on the latter, Business France recently released its “ 2015 Annual Report: Foreign Investment in France—The International Development of the French Economy. “ Findings from the report demonstrate that the efforts we are making in France to attract foreign business are working. For example, in 2015 we saw a 27 percent increase in jobs generated by foreign investment over 2014 figures, and 53 different countries invested in 2015, up from 47 in 2014. Broadly, we have 19 new investment decisions per week. As a reminder, 20,000 foreign companies are operating in France and employing almost 2 million people. Read the full editorial and learn more about France’s appeal on the Huffington Post’s website

7th French Pavilion at Suppliers’ Day

Pauline MARIE - 07-avr.-2016 00:18:38

  We look forward to greeting you for the launch of the 7th edition of the French Pavilion on Suppliers’ Day. French cosmetics ingredients manufacturers and testing companies will present their latest innovations at the show, on May 10th and 11th in Edison, NJ. BUSINESS FRANCE is proud to introduce this year’s Pavilion’s 10 exhibitors: •ALDIVIA, •AGRIMER, •BIOALTERNATIVES, •CIMAPREM, •DERMSCAN, •EOTECH, •INTERPOLYMER, •MINASOLVE, •PACIFIQUE SUD COSMETIQUE, •TOTAL FLUIDES. For more info about the Pavilion and the companies, please visit our dedicated website . To get the most up to date information, follow us on Twitter @BF_beautycare and on our Facebook!

17 French Eyewear Companies to Keep an Eye on at Vision Expo East

Elodie Fayn - 07-avr.-2016 00:05:52

  Business France is pleased to introduce the fourth International Vision Expo East French Pavilion in New York, in partnership with Lunettes de France, a national umbrella of eyewear trade associations from Paris, Oyonnax and Jura.   The event will take place April 15 th to 17 th 2016 at the Vision Expo East Show. The French Pavilion will showcase 17 of the finest French companies in the eyewear industry offering contemporary and timeless spectacles as well as unique accessories staging the latest trends and designs of the French expertise.   We would like to invite eyewear wholesale retailers, agents and press to visit the French Pavilion booths #6234-6245 & #6135-6141. For more information on the exhibiting French brands and location, please access the catalogue here .   To learn more about the 2016 International Vision Expo, go to www.visionexpoeast.com and for additional information please contact Elodie Fayn . Follow us on Twitter @BF_FashionStyle  and on Pinterest to get the latest news about the event.  

Meet Alizé RP - Business France Sponsor for the Upcoming BIO 2016 Convention

PRESS - 28-mars-2016 17:08:34

  Alize RP is a multilingual PR agency  (French, English, German and Spanish) specialized in Innovation with 4 domains of expertise: Biotech / Medtech; Healthcare / Cosmetics; Cleantech; and FinTech / Digital. Alize PR represents innovative businesses (start-ups, high-growth companies, pre- and post-exit phases) and private or listed companies in emerging markets, as well as industry bodies and state-owned organisms. We offer a wide range of services including : global communications campaigns ; digital campaigns; media relations in France, Europe and the US; press document development; crisis communication strategy; events ; and Graphic Design. We are not just experts in PR – we are also experts in a specific sector: Innovation. Our sharp focus means that we know all the key media, institutional and industry players & stakeholders in this specific market. Based on our in-depth market & segment knowledge, we are able to offer a tailor-made solution to each of our clients.        

About us
Arnaud Leretour: "Welcome to Business France North America! We assist French companies who want to export in North America, and North American companies who want to invest in France. Our team has both the knowledge and the experience to facilitate BtoB trade relations between the three countries. With offices and branches in New York, Boston, Toronto, Montréal, Atlanta, Detroit, Chicago, Houston, Vancouver, and San Francisco, Business France North America is present from coast to coast. Close to 100 Business France experts focus on the following sectors: - Agrotech (wine, spirits, beer, beverages, food, and equipments for the agricultural and food industry) - Industry & clean tech (public works & transportation, energy & clean techs, industry) - Art de vivre & healthcare (biotechnologies, cosmetics, healthcare, fashion, luxury, culture, sport, home decor and tourism) - Tech & services (new technologies, retail and services, innovati

READ MORE

    
    You Buy France 

    

    Rail industry 

   

    Vivapolis  

   

    Healthindustry

   

    Axema

          
   
Facebook
Press area & Media Gallery
List of last comments